✦ LIBER ✦

PIN7 COST MINIMIZATION ANALYSIS OF ORAL VALGANCICLOVIR VS. INTRAVENOUS AND ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS

✍ Scribed by M Rubio; F Oppenheimer; S Magaz; X Badia

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Valganciclovir vs

✍ Carlos Paya; Atul Humar; Ed Dominguez; Kenneth Washburn; Emily Blumberg; Barbara 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Oral Valganciclovir Is Noninferior to In

✍ A. Åsberg; A. Humar; H. Rollag; A. G. Jardine; H. Mouas; M. D. Pescovitz; D. Sga 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

PIN30 COST-MINIMIZATION ANALYSIS OF ORAL

✍ E David-Neto; ACC Toledo Jr; VD Nasciben; MG Saggia 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Analysis of HHV-6 mutations in solid org

✍ Bounaadja, Lotfi; Piret, Jocelyne; Goyette, Nathalie; Boivin, Guy 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 485 KB

Prevention of primary cytomegalovirus di

✍ R.H. Rubin; S.A. Kemmerly; D. Conti; M. Doran; B.M. Murray; J.F. Neylan; C. Papp 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

The efficacy and safety of valganciclovi

✍ E. Lapidus-Krol; R. Shapiro; J. Amir; M. Davidovits; R. Steinberg; E. Mor; Y. Av 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB